Using advanced technology to assess breast cancer risk while protecting patient privacy
Privacy-Aware Federated Learning for Breast Cancer Risk Assessment
This study is exploring a new way for hospitals to work together to improve breast cancer risk assessments without sharing your personal data, so that everyone can get better and more accurate evaluations based on a wider variety of information.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10932257 on NIH RePORTER |
What this research studies
This research investigates a new method called federated learning, which allows multiple healthcare sites to analyze patient data without sharing it directly. By keeping data local, this approach addresses privacy concerns and enables the collection of diverse data from various populations. The goal is to develop robust models for breast cancer risk assessment that can be applied to different patient groups, ultimately improving early detection and treatment strategies. Patients may benefit from more accurate risk assessments based on a broader range of data.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for breast cancer or those undergoing routine screening.
Not a fit: Patients who are not at risk for breast cancer or those who do not undergo breast cancer screening may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved breast cancer risk assessments, allowing for earlier detection and better personalized treatment options.
How similar studies have performed: Other research has shown promise using federated learning in various medical fields, indicating potential for success in this novel application for breast cancer risk assessment.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Bakas, Spyridon — Indiana University Indianapolis
- Study coordinator: Bakas, Spyridon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.